Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-γ-activated macrophages

Journal of Leukocyte Biology

Volumn 68, Issue 2, 2000, Pages 260-266

  Chiarugi, Alberto ^a   Sbarba, Persio Dello ^a   Paccagnini, Alessandro ^a   Donnini, Sandra ^a   Filippi, Sandra ^a   Moroni, Flavio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

3OH kynurenine; Kynurenine pathway; Neuroinflammation; Nitric oxide; Quinolinic acid

Indexed keywords

BETA CARBOLINE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NITRIC OXIDE SYNTHASE; QUINOLINIC ACID;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENCEPHALITIS; ENZYME ACTIVITY; INFLAMMATION; MACROPHAGE; MONONUCLEAR PHAGOCYTE; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; KYNURENINE; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; QUINOLINIC ACID; TRYPTOPHAN OXYGENASE;

ANIMALIA; MURINAE;

EID: 0033862663     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease
2. Tryptophan metabolism and brain function: Focus on kynurenine and other indole metabolites
3. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: Relationship to clinical and neurological status
4. Microglia as mediators of inflammatory and degenerative diseases
5. Models of neuronal injury in AIDS: Another role for the NMDA receptor?
6. Mechanism of delayed increase in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia
7. Kynurenine hydroxylase inhibitors reduce ischemic brain damage: Studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-ben-zenesulphonamide (Ro 61-8048) in models of focal and global brain ischemia
8. Quinolinic acid accumulation in injured spinal cord: Time course, distribution and species differences between rat and guinea pig
9. Interferons in multiple sclerosis: A review of evidence
10. Treatment of MS with gamma interferon: Exacerbations associated with activation of the immune system
11. Measles virus-induced hippocampal neurodegeneration in the mouse: A novel, subacute model for testing neuroprotective agents
12. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway m experimental cerebral and non cerebral malaria
13. 4-Chloro-3-hydroxyanthranilate, 6-chlorotyptophan and norharmane attenuate quinolinic acid formation by interferon-γ-stimulated monocytes (THP-1 cells)
14. Localization of quinolinic acid in the routine AIDS model of retrovirus-induced immunodeficiency: Implications for neurotoxicity and dendritic cell immunopathogenesis
15. Regulation of the kynurenine pathway by intereron-γ in murine cloned macrophages and microglial cells
16. Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase
17. Infuence of interferon-gamma and extracellular tryptophan on indoleamine 2,3-dioxygenase activity in T24 cells as determined by a non-radiometric assay
18. Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha
19. Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effects
20. Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism
21. 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and regional selectivity
22. Hydogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine
23. Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain
24. Neuropharmacology of quinolinic and kynurenic acids
25. Nitric oxide: Physiology, pathophysiology, and pharmacology
26. Release of nitric oxide from astroglial cells: A key mechanism in neuroimmune disorders
27. The nitric oxide hypothesis of brain aging
28. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide
29. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmnne encephalomyelitis
30. New insights into the regulation of inducible nitric oxide synthase
31. Nitric oxide synthases: Roles, tolls, and controls
32. Inhibition of indoleamine 2,3-dioxygenase and tryptophan dioxygenase by b-carboline derivatives
33. Isolation and characterization of a cloned growth factor dependent macrophage cell line BAC1.2F5
34. Venular endothelial cells from bovine heart
35. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production
36. Middle T antigen transformed endothelial cells exibit an increased activity of nitric oxide synthase
37. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenic acid and have sedative and anticonvulsant activities
38. Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by HPLC
39. Quantification of 3-hydroxykynurenine in the brain by HPLC and electrochemical detection
40. Quantification of quinolinic acid in rat brain, whole blood and plasma by gas chromatography and negative chemical ionization mass spectrometry: Effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations
41. Synthesis of nitrogen oxide from L-arginine by macrophage cytosol: Requirement for inducible and constitutive components
42. Substance P increases cyclic GMP levels on coronary postcapillary venular endothelial cells
43. Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system
44. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1
45. Circulating adhesion molecules and inflammatory mediators in demyelination: A review
46. The role of tumor necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system
47. Hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter
48. Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon gamma primed mononuclear phagocytes
49. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenylene iodonium and its analogs
50. Innate and adaptative immune response can be beneficial for CNS repair
51. Molecular profile of reactive astrocytes, implication for their role in neurologic disease
52. Cytotoxicity of microglia
53. Therapeutic approaches to the treatment of neuroinflammatory diseases